BEST1 and Alzheimer disease: This has also been shown in AD mouse models, where accumulating GABA is abnormally released from reactive astrocytes through bestrophin 1 channels, which impairs learning and memory (Jo et al., 2014) The high astrocytic GABA level identified in human brains with high Aβ load may thus be used as a novel biomarker and diagnostic tool for AD.